Clinical Trial Update: The Role of Gastroesophageal Reflux in Scleroderma Pulmonary Fibrosis

View source ↗

Summary

A clinical trial update evaluating the role of gastroesophageal reflux in scleroderma-related pulmonary fibrosis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Interstitial Lung Disease
• Systemic Sclerosis

Snippet

Sponsor: Royal Brompton & Harefield NHS Foundation Trust | Conditions: Interstitial Lung Disease, Systemic Sclerosis | Status: UNKNOWN